The DOI matches its Crossref record; 147 of the 147 references it cites were found in a registry or an index.
Molecular Mechanisms and Biological Functions of siRNA
Open accessAbstract
One of the most important advances in biology has been the discovery that siRNA (small interfering RNA) is able to regulate the expression of genes, by a phenomenon known as RNAi (RNA interference). The discovery of RNAi, first in plants and Caenorhabditis elegans and later in mammalian cells, led to the emergence of a transformative view in biomedical research. siRNA has gained attention as a potential therapeutic reagent due to its ability to inhibit specific genes in many genetic diseases. siRNAs can be used as tools to study single gene function both in vivo and in-vitro and are an attractive new class of therapeutics, especially against undruggable targets for the treatment of cancer and other diseases. The siRNA delivery systems are categorized as non-viral and viral delivery systems. The non-viral delivery system includes polymers; Lipids; peptides etc. are the widely studied delivery systems for siRNA. Effective pharmacological use of siRNA requires ‘carriers’ that can deliver the siRNA to its intended site of action. The carriers assemble the siRNA into supramolecular complexes that display functional properties during the delivery process.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans
Fire, A., Xu, S., Montgomery, M. K., Kostas, S. A., Driver, S. E., & Mello, C. C. (1998) · Nature · doi:10.1038/35888 · Cited by 15,429
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells
Elbashir, S. M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., & Tuschl, T. (2001) · Nature · doi:10.1038/35078107 · Cited by 9,456
Origins and Mechanisms of miRNAs and siRNAs
Carthew, R. W., & Sontheimer, E. J. (2009) · Cell · doi:10.1016/j.cell.2009.01.035 · Cited by 5,018
Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure.
Felgner, P. L., Gadek, T. R., Holm, M., Roman, R., Chan, H. W., Wenz, M., Northrop, J. P., Ringold, G. M., & Danielsen, M. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7413 · Cited by 4,978
Role for a bidentate ribonuclease in the initiation step of RNA interference
Bernstein, E., Caudy, A. A., Hammond, S. M., & Hannon, G. J. (2001) · Nature · doi:10.1038/35053110 · Cited by 4,892
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
Gerold, G., & Pietschmann, T. (2014) · Digestive Diseases · doi:10.1159/000360830 · Cited by 4,854
A System for Stable Expression of Short Interfering RNAs in Mammalian Cells
Brummelkamp, T. R., Bernards, R., & Agami, R. (2002) · Science · doi:10.1126/science.1068999 · Cited by 4,291
Block copolymer micelles for drug delivery: design, characterization and biological significance
Kataoka, K., Harada, A., & Nagasaki, Y. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00124-1 · Cited by 3,506
Non-viral vectors for gene-based therapy
Yin, H., Kanasty, R. L., Eltoukhy, A. A., Vegas, A. J., Dorkin, J. R., & Anderson, D. G. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3763 · Cited by 3,123
An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells
Hammond, S. M., Bernstein, E., Beach, D., & Hannon, G. J. (2000) · Nature · doi:10.1038/35005107 · Cited by 3,003
Argonaute2 is the catalytic engine of mammalian RNAi
Liu, J., Carmell, M. A., Rivas, F. V., Marsden, C. G., Thomson, J. M., Song, J.-J., Hammond, S. M., Joshua-Tor, L., & Hannon, G. J. (2004) · Science · doi:10.1126/science.1102513 · Cited by 2,796
Cellular uptake of the tat protein from human immunodeficiency virus
Frankel, A. D., & Pabo, C. O. (1988) · Cell · doi:10.1016/0092-8674(88)90263-2 · Cited by 2,783
Zamore, P. D., Tuschl, T., Sharp, P. A., & Bartel, D. P. (2000) · Cell · doi:10.1016/s0092-8674(00)80620-0 · Cited by 2,676
Functional siRNAs and miRNAs exhibit strand bias
Khvorova, A., Reynolds, A., & Jayasena, S. D. (2003) · Cell · doi:10.1016/s0092-8674(03)00801-8 · Cited by 2,645
Mechanisms of gene silencing by double-stranded RNA
Meister, G., & Tuschl, T. (2004) · Nature · doi:10.1038/nature02873 · Cited by 2,539
Long Noncoding RNAs: Cellular Address Codes in Development and Disease
Batista, P. J., & Chang, H. Y. (2013) · Cell · doi:10.1016/j.cell.2013.02.012 · Cited by 2,531
Expression profiling reveals off-target gene regulation by RNAi
Jackson, A. L., Bartz, S. R., Schelter, J., Kobayashi, S. V., Burchard, J., Mao, M., Li, B., Cavet, G., & Linsley, P. S. (2003) · Nature Biotechnology · doi:10.1038/nbt831 · Cited by 2,370
Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs
Soutschek, J., Akinc, A., Bramlage, B., Charisse, K., Constien, R., Donoghue, M., Elbashir, S., Geick, A., Hadwiger, P., Harborth, J., et al. (2004) · Nature · doi:10.1038/nature03121 · Cited by 2,183
Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs
Meister, G., Landthaler, M., Patkaniowska, A., Dorsett, Y., Teng, G., & Tuschl, T. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.07.007 · Cited by 2,052
Rational design of cationic lipids for siRNA delivery
Semple, S. C., Akinc, A., Chen, J., Sandhu, A. P., Mui, B. L., Cho, C. K., Sah, D. W. Y., Stebbing, D., Crosley, E. J., Yaworski, E., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1602 · Cited by 1,822 · cited 1×
“Lipid-based systems include liposomes, micelles, emulsions, and solid lipid nanoparticles (108-121).”
BackgroundGreen, M., & Loewenstein, P. M. (1988) · Cell · doi:10.1016/0092-8674(88)90262-0 · Cited by 1,553
Crystal Structure of Argonaute and Its Implications for RISC Slicer Activity
Song, J.-J., Smith, S. K., Hannon, G. J., & Joshua-Tor, L. (2004) · Science · doi:10.1126/science.1102514 · Cited by 1,470
RNAi-mediated gene silencing in non-human primates
Zimmermann, T. S., Lee, A. C. H., Akinc, A., Bramlage, B., Bumcrot, D., Fedoruk, M. N., Harborth, J., Heyes, J. A., Jeffs, L. B., John, M., et al. (2006) · Nature · doi:10.1038/nature04688 · Cited by 1,357 · cited 1×
“Lipid-based systems include liposomes, micelles, emulsions, and solid lipid nanoparticles (108-121).”
BackgroundSequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA
Judge, A. D., Sood, V., Shaw, J. R., Fang, D., McClintock, K., & MacLachlan, I. (2005) · Nature Biotechnology · doi:10.1038/nbt1081 · Cited by 1,250
Transvascular delivery of small interfering RNA to the central nervous system
Kumar, P., Wu, H., McBride, J. L., Jung, K.-E., Hee Kim, M., Davidson, B. L., Kyung Lee, S., Shankar, P., & Manjunath, N. (2007) · Nature · doi:10.1038/nature05901 · Cited by 1,246
The promises and pitfalls of RNA-interference-based therapeutics
Castanotto, D., & Rossi, J. J. (2009) · Nature · doi:10.1038/nature07758 · Cited by 1,221
A Slicer-Mediated Mechanism for Repeat-Associated siRNA 5' End Formation in Drosophila
Gunawardane, L. S., Saito, K., Nishida, K. M., Miyoshi, K., Kawamura, Y., Nagami, T., Siomi, H., & Siomi, M. C. (2007) · Science · doi:10.1126/science.1140494 · Cited by 1,171
Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs
Morrissey, D. V., Lockridge, J. A., Shaw, L., Blanchard, K., Jensen, K., Breen, W., Hartsough, K., Machemer, L., Radka, S., Jadhav, V., et al. (2005) · Nature Biotechnology · doi:10.1038/nbt1122 · Cited by 1,168
A combinatorial library of lipid-like materials for delivery of RNAi therapeutics
Akinc, A., Zumbuehl, A., Goldberg, M., Leshchiner, E. S., Busini, V., Hossain, N., Bacallado, S. A., Nguyen, D. N., Fuller, J., Alvarez, R., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1402 · Cited by 1,150
RNA interference targeting Fas protects mice from fulminant hepatitis
Song, E., Lee, S.-K., Wang, J., Ince, N., Ouyang, N., Min, J., Chen, J., Shankar, P., & Lieberman, J. (2003) · Nature Medicine · doi:10.1038/nm828 · Cited by 1,110
RNAi therapeutics: a potential new class of pharmaceutical drugs
Bumcrot, D., Manoharan, M., Koteliansky, V., & Sah, D. W. Y. (2006) · Nature Chemical Biology · doi:10.1038/nchembio839 · Cited by 1,085
Jackson, A. L., & Linsley, P. S. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3010 · Cited by 1,083
Molecular Mechanisms of RNA Interference
Wilson, R. C., & Doudna, J. A. (2013) · Annual Review of Biophysics · doi:10.1146/annurev-biophys-083012-130404 · Cited by 1,076
Galectin 8 targets damaged vesicles for autophagy to defend cells against bacterial invasion
Thurston, T. L. M., Wandel, M. P., von Muhlinen, N., Foeglein, Á., & Randow, F. (2012) · Nature · doi:10.1038/nature10744 · Cited by 1,034
Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors
Song, E., Zhu, P., Lee, S.-K., Chowdhury, D., Kussman, S., Dykxhoorn, D. M., Feng, Y., Palliser, D., Weiner, D. B., Shankar, P., et al. (2005) · Nature Biotechnology · doi:10.1038/nbt1101 · Cited by 1,021
Cell type–specific delivery of siRNAs with aptamer-siRNA chimeras
McNamara, J. O., Andrechek, E. R., Wang, Y., Viles, K. D., Rempel, R. E., Gilboa, E., Sullenger, B. A., & Giangrande, P. H. (2006) · Nature Biotechnology · doi:10.1038/nbt1223 · Cited by 1,002
Gibbings, D. J., Ciaudo, C., Erhardt, M., & Voinnet, O. (2009) · Nature Cell Biology · doi:10.1038/ncb1929 · Cited by 991
Polyethylenimine-based non-viral gene delivery systems
Lungwitz, U., Breunig, M., Blunk, T., & Göpferich, A. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.11.011 · Cited by 983
Perspective: machines for RNAi
Tomari, Y., & Zamore, P. D. (2005) · Genes & Development · doi:10.1101/gad.1284105 · Cited by 948
3′ UTR seed matches, but not overall identity, are associated with RNAi off-targets
Birmingham, A., Anderson, E. M., Reynolds, A., Ilsley-Tyree, D., Leake, D., Fedorov, Y., Baskerville, S., Maksimova, E., Robinson, K., Karpilow, J., et al. (2006) · Nature Methods · doi:10.1038/nmeth854 · Cited by 920
Cationic liposome-mediated RNA transfection.
Malone, R. W., Felgner, P. L., & Verma, I. M. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.16.6077 · Cited by 911
An Analysis of Human MicroRNA and Disease Associations
Lu, M., Zhang, Q., Deng, M., Miao, J., Guo, Y., Gao, W., & Cui, Q. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003420 · Cited by 902
Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy
Kim, D.-H., Behlke, M. A., Rose, S. D., Chang, M.-S., Choi, S., & Rossi, J. J. (2005) · Nature Biotechnology · doi:10.1038/nbt1051 · Cited by 884
RNA interference in the clinic: challenges and future directions
Pecot, C. V., Calin, G. A., Coleman, R. L., Lopez-Berestein, G., & Sood, A. K. (2011) · Nature Reviews Cancer · doi:10.1038/nrc2966 · Cited by 820
Kunath, K. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00076-2 · Cited by 809
Non-coding RNAs as regulators of gene expression and epigenetics
Kaikkonen, M. U., Lam, M. T. Y., & Glass, C. K. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr097 · Cited by 764
A three-dimensional view of the molecular machinery of RNA interference
Jinek, M., & Doudna, J. A. (2009) · Nature · doi:10.1038/nature07755 · Cited by 744
Urban-Klein, B., Werth, S., Abuharbeid, S., Czubayko, F., & Aigner, A. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302425 · Cited by 716
Evolution of microRNA diversity and regulation in animals
Berezikov, E. (2011) · Nature Reviews Genetics · doi:10.1038/nrg3079 · Cited by 712
Therapeutic EphA2 Gene Targeting In vivo Using Neutral Liposomal Small Interfering RNA Delivery
Landen, C. N., Chavez-Reyes, A., Bucana, C., Schmandt, R., Deavers, M. T., Lopez-Berestein, G., & Sood, A. K. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0530 · Cited by 675
siRNA vs. shRNA: Similarities and differences
Rao, D. D., Vorhies, J. S., Senzer, N., & Nemunaitis, J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.04.004 · Cited by 660
Dynamic PolyConjugates for targeted in vivo delivery of siRNA to hepatocytes
Rozema, D. B., Lewis, D. L., Wakefield, D. H., Wong, S. C., Klein, J. J., Roesch, P. L., Bertin, S. L., Reppen, T. W., Chu, Q., Blokhin, A. V., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703778104 · Cited by 658
Yigit, E., Batista, P. J., Bei, Y., Pang, K. M., Chen, C.-C. G., Tolia, N. H., Joshua-Tor, L., Mitani, S., Simard, M. J., & Mello, C. C. (2006) · Cell · doi:10.1016/j.cell.2006.09.033 · Cited by 650
siRNA delivery systems for cancer treatment
Oh, Y.-K., & Park, T. G. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.04.018 · Cited by 645
Lipid-based Nanoparticles for Nucleic Acid Delivery
Li, W., & Szoka, F. C. (2007) · Pharmaceutical Research · doi:10.1007/s11095-006-9180-5 · Cited by 641
T Cell-Specific siRNA Delivery Suppresses HIV-1 Infection in Humanized Mice
Kumar, P., Ban, H.-S., Kim, S.-S., Wu, H., Pearson, T., Greiner, D. L., Laouar, A., Yao, J., Haridas, V., Habiro, K., et al. (2008) · Cell · doi:10.1016/j.cell.2008.06.034 · Cited by 570
Hu-Lieskovan, S., Heidel, J. D., Bartlett, D. W., Davis, M. E., & Triche, T. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0565 · Cited by 567
Exosomes for targeted siRNA delivery across biological barriers
EL Andaloussi, S., Lakhal, S., Mäger, I., & Wood, M. J. A. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.08.008 · Cited by 539
Gary, D. J., Puri, N., & Won, Y.-Y. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.05.021 · Cited by 514
pH-sensitive vesicles, polymeric micelles, and nanospheres prepared with polycarboxylates
Felber, A. E., Dufresne, M.-H., & Leroux, J.-C. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.09.006 · Cited by 478
Nonviral delivery of synthetic siRNAs in vivo
Akhtar, S., & Benter, I. F. (2007) · Journal of Clinical Investigation · doi:10.1172/jci33494 · Cited by 464
HUNTER, A. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.09.008 · Cited by 456
Chemically modified siRNA: tools and applications
Watts, J. K., Deleavey, G. F., & Damha, M. J. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2008.05.007 · Cited by 431
Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotides
Juliano, R., Alam, M. R., Dixit, V., & Kang, H. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn342 · Cited by 429
Cationic lipids and polymers mediated vectors for delivery of siRNA
Zhang, S., Zhao, B., Jiang, H., Wang, B., & Ma, B. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.07.016 · Cited by 421
Therapeutic siRNA: principles, challenges, and strategies.
Gavrilov, K., & Saltzman, W. M. (2012) · PubMed Central · Cited by 419
Tünnemann, G., Martin, R. M., Haupt, S., Patsch, C., Edenhofer, F., & Cardoso, M. C. (2006) · The FASEB Journal · doi:10.1096/fj.05-5523com · Cited by 402
RNA interference: From gene silencing to gene-specific therapeutics
Leung, R. K. M., & Whittaker, P. A. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.03.004 · Cited by 382
Visualizing a Correlation between siRNA Localization, Cellular Uptake, and RNAi in Living Cells
Chiu, Y.-L., Ali, A., Chu, C.-Y., Cao, H., & Rana, T. M. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.06.006 · Cited by 381
Kortylewski, M., Swiderski, P., Herrmann, A., Wang, L., Kowolik, C., Kujawski, M., Lee, H., Scuto, A., Liu, Y., Yang, C., et al. (2009) · Nature Biotechnology · doi:10.1038/nbt.1564 · Cited by 380
RNA Interference (RNAi)-Based Therapeutics: Delivering on the Promise?
Bobbin, M. L., & Rossi, J. J. (2016) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010715-103633 · Cited by 353
Prospects of RNA interference therapy for cancer
Pai, S. I., Lin, Y.-Y., Macaes, B., Meneshian, A., Hung, C.-F., & Wu, T.-C. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302694 · Cited by 352
Moschos, S. A., Jones, S. W., Perry, M. M., Williams, A. E., Erjefalt, J. S., Turner, J. J., Barnes, P. J., Sproat, B. S., Gait, M. J., & Lindsay, M. A. (2007) · Bioconjugate Chemistry · doi:10.1021/bc070077d · Cited by 350
Chemical modification of siRNAs to improve serum stability without loss of efficacy
Choung, S., Kim, Y. J., Kim, S., Park, H.-O., & Choi, Y.-C. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.02.049 · Cited by 348
Optimized galenics improve in vitro gene transfer with cationic molecules up to 1000-fold.
Boussif, O., Zanta, M. A., & Behr, J. (1996) · PubMed · Cited by 342
Steroid and lipid conjugates of siRNAs to enhance cellular uptake and gene silencing in liver cells
Lorenz, C., Hadwiger, P., John, M., Vornlocher, H.-P., & Unverzagt, C. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.07.018 · Cited by 338
Tumor-targeted Delivery of siRNA by Self-assembled Nanoparticles
Li, S.-D., Chen, Y.-C., Hackett, M. J., & Huang, L. (2008) · Molecular Therapy · doi:10.1038/sj.mt.6300323 · Cited by 333
Efficient In Vivo Delivery of siRNA to the Liver by Conjugation of α-Tocopherol
Nishina, K., Unno, T., Uno, Y., Kubodera, T., Kanouchi, T., Mizusawa, H., & Yokota, T. (2008) · Molecular Therapy · doi:10.1038/mt.2008.14 · Cited by 312
Sato, Y., Hatakeyama, H., Sakurai, Y., Hyodo, M., Akita, H., & Harashima, H. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.09.009 · Cited by 309
Engineering RNA for Targeted siRNA Delivery and Medical Application
Guo, P., Coban, O., Snead, N. M., Trebley, J., Hoeprich, S., Guo, S., & Shu, Y. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.03.008 · Cited by 300
Gene therapy progress and prospects: synthetic polymer-based systems
Schaffert, D., & Wagner, E. (2008) · Gene Therapy · doi:10.1038/gt.2008.105 · Cited by 277
Peer, D., Zhu, P., Carman, C. V., Lieberman, J., & Shimaoka, M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608491104 · Cited by 275
Nanoparticle-based delivery of small interfering RNA: challenges for cancer therapy
Gulino, A. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s23696 · Cited by 258
Hatakeyama, H., Ito, E., Akita, H., Oishi, M., Nagasaki, Y., Futaki, S., & Harashima, H. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.06.008 · Cited by 254
Utilizing RNA interference to enhance cancer drug discovery
Iorns, E., Lord, C. J., Turner, N., & Ashworth, A. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2355 · Cited by 251
Cellular siRNA delivery using cell-penetrating peptides modified for endosomal escape
Endoh, T., & Ohtsuki, T. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.04.005 · Cited by 242
Check, E. (2002) · Nature · doi:10.1038/420116a · Cited by 238
Antitumor Activity of Small Interfering RNA/Cationic Liposome Complex in Mouse Models of Cancer
Yano, J., Hirabayashi, K., Nakagawa, S.-I., Yamaguchi, T., Nogawa, M., Kashimori, I., Naito, H., Kitagawa, H., Ishiyama, K., Ohgi, T., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1049 · Cited by 238
Grzelinski, M., Urban-Klein, B., Martens, T., Lamszus, K., Bakowsky, U., Höbel, S., Czubayko, F., & Aigner, A. (2006) · Human Gene Therapy · doi:10.1089/hum.2006.17.751 · Cited by 234
Li, S., Wu, S.-P., Whitmore, M., Loeffert, E. J., Wang, L., Watkins, S. C., Pitt, B. R., & Huang, L. (1999) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1999.276.5.l796 · Cited by 225
Gene delivery by cationic lipid vectors: overcoming cellular barriers
Zuhorn, I. S., Engberts, J. B. F. N., & Hoekstra, D. (2007) · European Biophysics Journal · doi:10.1007/s00249-006-0092-4 · Cited by 224
Mechanistic aspects of CPP-mediated intracellular drug delivery: Relevance of CPP self-assembly
Pujals, S., Fernández-Carneado, J., López-Iglesias, C., Kogan, M. J., & Giralt, E. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.01.006 · Cited by 223
RNA Interference Therapy in Lung Transplant Patients Infected with Respiratory Syncytial Virus
Zamora, M. R., Budev, M., Rolfe, M., Gottlieb, J., Humar, A., DeVincenzo, J., Vaishnaw, A., Cehelsky, J., Albert, G., Nochur, S., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201003-0422oc · Cited by 210
Application of membrane-active peptides for nonviral gene delivery
Wagner, E. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(99)00033-2 · Cited by 194
Targeted Delivery of PLK1-siRNA by ScFv Suppresses Her2 + Breast Cancer Growth and Metastasis
Yao, Y.-D., Sun, T.-M., Huang, S.-Y., Dou, S., Lin, L., Chen, J.-N., Ruan, J.-B., Mao, C.-Q., Yu, F.-Y., Zeng, M.-S., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003601 · Cited by 188
Rajeev, K. G., Nair, J. K., Jayaraman, M., Charisse, K., Taneja, N., O'Shea, J., Willoughby, J. L. S., Yucius, K., Nguyen, T., Shulga‐Morskaya, S., et al. (2015) · ChemBioChem · doi:10.1002/cbic.201500023 · Cited by 185
Santel, A., Aleku, M., Keil, O., Endruschat, J., Esche, V, Durieux, B., Löffler, K., Fechtner, M., Röhl, T., Fisch, G., et al. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302778 · Cited by 183
Chen, P. Y., Weinmann, L., Gaidatzis, D., Pei, Y., Zavolan, M., Tuschl, T., & Meister, G. (2008) · RNA · doi:10.1261/rna.789808 · Cited by 176
Small RNAs derived from longer non-coding RNAs
Röther, S., & Meister, G. (2011) · Biochimie · doi:10.1016/j.biochi.2011.07.032 · Cited by 175
Systemic and Specific Delivery of Small Interfering RNAs to the Liver Mediated by Apolipoprotein A-I
Kim, S. I., Shin, D., Choi, T. H., Lee, J. C., Cheon, G.-J., Kim, K.-Y., Park, M., & Kim, M. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300168 · Cited by 169
Pillé, J.-Y., Li, H., Blot, E., Bertrand, J.-R., Pritchard, L.-L., Opolon, P., Maksimenko, A., Lu, H., Vannier, J.-P., Soria, J., et al. (2006) · Human Gene Therapy · doi:10.1089/hum.2006.17.1019 · Cited by 167
Efficient siRNA Delivery with Non-viral Polymeric Vehicles
Kim, W. J., & Kim, S. W. (2009) · Pharmaceutical Research · doi:10.1007/s11095-008-9774-1 · Cited by 166
A pH-Sensitive Polymer That Enhances Cationic Lipid-Mediated Gene Transfer
Cheung, C. Y., Murthy, N., Stayton, P. S., & Hoffman, A. S. (2001) · Bioconjugate Chemistry · doi:10.1021/bc0100408 · Cited by 164
Improved and automated prediction of effective siRNA
Chalk, A. M., Wahlestedt, C., & Sonnhammer, E. L. L. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.04.181 · Cited by 160
Fusogenic peptides enhance endosomal escape improving siRNA-induced silencing of oncogenes
Oliveira, S., VANROOY, I., Kranenburg, O., Storm, G., & Schiffelers, R. M. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.11.050 · Cited by 155
Taratula, O., Garbuzenko, O. B., Savla, R., Wang, Y. A., He, H., & Minko, T. (2010) · Current Drug Delivery · doi:10.2174/156720111793663642 · Cited by 154
Synthesis of Cluster Galactosides with High Affinity for the Hepatic Asialoglycoprotein Receptor
Biessen, E. A. L., Beuting, D. M., Roelen, H. C. P. F., van der MAREL, G. A., BOOM, J. H. V., & van Berkel, T. J. C. (1995) · Journal of Medicinal Chemistry · doi:10.1021/jm00009a014 · Cited by 151
Supramolecular assemblies in functional siRNA delivery: Where do we stand?
Aliabadi, H. M., Landry, B. K., Sun, C., Tang, T., & Uludağ, H. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.11.079 · Cited by 146
RNA interference therapeutics for cancer: Challenges and opportunities (Review)
Bora, R. S., Gupta, D., Mukkur, T. K. S., & Saini, K. S. (2012) · Molecular Medicine Reports · doi:10.3892/mmr.2012.871 · Cited by 141
Pillé, J.-Y., Li, H., Blot, E., Bertrand, J., Pritchard, L. L., Opolon, P., Maksimenko, A., Lu, H., Vannier, J., Soria, J., et al. (2006) · Human Gene Therapy · doi:10.1089/hum.2006.17.ft-248 · Cited by 140
Viral vector-mediated RNA interference
Couto, L. B., & High, K. A. (2010) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2010.06.007 · Cited by 139
Liu, Y., Zhu, Y., Mao, C., Dou, S., Shen, S., Tan, Z., & Wang, J. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.07.001 · Cited by 138
Hobo, W. A., Novobrantseva, T. I., Fredrix, H., Wong, J., Milstein, S., Epstein-Barash, H., Liu, J., Schaap, N. P., van der Voort, R., & Dolstra, H. (2012) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-012-1334-1 · Cited by 130
Degradable polyethylenimines as DNA and small interfering RNA carriers
Jere, D., Jiang, H., Arote, R. B., Kim, Y., Choi, Y., Cho, M., Akaike, T., & Cho, C. S. (2009) · Expert Opinion on Drug Delivery · doi:10.1517/17425240903029183 · Cited by 120
RNAi therapeutics: an update on delivery.
Nguyen, T. A., Menocal, E. M., Harborth, J., & Fruehauf, J. H. (2008) · PubMed · Cited by 111
Blum, J. S., & Saltzman, W. M. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.04.002 · Cited by 108
Non-viral nanocarriers for siRNA delivery in breast cancer
Zhang, J., Li, X., & Huang, L. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.05.037 · Cited by 106
Fischer, D., von Harpe, A., Kunath, K., Petersen, H., Li, Y., & Kissel, T. (2002) · Bioconjugate Chemistry · doi:10.1021/bc025550w · Cited by 105
Pal, A., Ahmad, A., Khan, S., Sakabe, I., Zhang, C., Kasid, U. N., & Ahmad, I. (2005) · International Journal of Oncology · doi:10.3892/ijo.26.4.1087 · Cited by 104
Delivery of siRNA into breast cancer cells via phage fusion protein-targeted liposomes
Bedi, D., Musacchio, T., Fagbohun, O. A., Gillespie, J. W., DeInnocentes, P., Bird, R. C., Bookbinder, L., Torchilin, V. P., & Petrenko, V. A. (2010) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2010.10.004 · Cited by 104
Xu, C., Jere, D., Jin, H., Chang, S.-H., Chung, Y.-S., Shin, J., Kim, J., Park, S. J., Lee, Y.-H., Chae, C., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200707-1022oc · Cited by 102
Wong, S. C., Klein, J. J., Hamilton, H., Chu, Q., Frey, C. L., Trubetskoy, V. S., Hegge, J., Wakefield, D. H., Rozema, D. B., & Lewis, D. L. (2012) · Nucleic Acid Therapeutics · doi:10.1089/nat.2012.0389 · Cited by 101
Therapeutic targeting in the silent era: advances in non-viral siRNA delivery
Guo, J., Fisher, K. A., Darcy, R., Cryan, J. F., & O’Driscoll, C. M. (2010) · Molecular BioSystems · doi:10.1039/c001050m · Cited by 100
Mechanisms of nanoparticle-mediated siRNA transfection by melittin-derived peptides
Hou, K. K., Pan, H., Ratner, L., Schlesinger, P. H., & Wickline, S. A. (2013) · ACS Nano · doi:10.1021/nn403311c · Cited by 95
Lee, J. B., Zhang, K., Tam, Y. Y. C., Tam, Y. K., Belliveau, N. M., Sung, V. Y. C., Lin, P. J. C., LeBlanc, E., Ciufolini, M. A., Rennie, P. S., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.27361 · Cited by 92
Yagi, N., Manabe, I., Tottori, T., Ishihara, A., Ogata, F., Kim, J. H., Nishimura, S., Fujiu, K., Oishi, Y., Itaka, K., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3945 · Cited by 92
Nanoparticle-Based Delivery System for Application of siRNA In Vivo
Wang, Y., Li, Z., Han, Y., Leo, H. L., & Ji, A. (2010) · Current Drug Metabolism · doi:10.2174/138920010791110863 · Cited by 88
Biomaterials in siRNA Delivery: A Comprehensive Review
Ho, W., Zhang, X., & Xu, X. (2016) · Advanced Healthcare Materials · doi:10.1002/adhm.201600418 · Cited by 88
A role for peptides in overcoming endosomal entrapment in siRNA delivery — A focus on melittin
Hou, K. K., Pan, H., Schlesinger, P. H., & Wickline, S. A. (2015) · Biotechnology Advances · doi:10.1016/j.biotechadv.2015.05.005 · Cited by 86
Pulford, B., Reim, N., Bell, A., Veatch, J., Forster, G., Bender, H., Meyerett, C., Hafeman, S., Michel, B., Johnson, T., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011085 · Cited by 85 · cited 2×
“Peptides, polymers, and Lipids are the extensively studied non-viral delivery vehicles (60-70).”
BackgroundFiltering of Ineffective siRNAs and Improved siRNA Design Tool
Yiu, S., Wong, P. W. H., Lam, T., Mui, Y.-C., Kung, H. F., Lin, M. C. M., & Cheung, Y.-T. (2004) · Bioinformatics · doi:10.1093/bioinformatics/bth498 · Cited by 81
Cesarone, G., Edupuganti, O. P., Chen, C.-P., & Wickstrom, E. (2007) · Bioconjugate Chemistry · doi:10.1021/bc070135v · Cited by 77
Choi, S. W., Hyeon, L. S., Mok, H., & Park, T. G. (2009) · Biotechnology Progress · doi:10.1002/btpr.310 · Cited by 74
Targeted therapy of cancer: new roles for pathologists—prostate cancer
Rubin, M. A. (2008) · Modern Pathology · doi:10.1038/modpathol.2008.11 · Cited by 57
Hogrefe, R. I., Lebedev, A. V., Zon, G., Pirollo, K. F., Rait, A. S., Zhou, Q., Yu, W., & Chang, E. H. (2006) · Nucleosides Nucleotides & Nucleic Acids · doi:10.1080/15257770600793885 · Cited by 56
Recent progress in copolymer-mediated siRNA delivery
Wu, Z.-W., Chien, C., Liu, C., Yan, J., & Lin, S. (2012) · Journal of drug targeting · doi:10.3109/1061186x.2012.699057 · Cited by 50
Designing Functional siRNA with Reduced Off-Target Effects
Naito, Y., & Ui‐Tei, K. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-119-6_3 · Cited by 44
Zhang, J., Pei, Y., Zhang, H., Wang, L., Arrington, L., Zhang, Y., Glass, A., & Leone, A. M. (2012) · Molecular Pharmaceutics · doi:10.1021/mp3005337 · Cited by 38
Lentiviral Vector-Mediated Gene Transfer and RNA Silencing Technology in Neuronal Dysfunctions
Dreyer, J. (2010) · Molecular Biotechnology · doi:10.1007/s12033-010-9334-x · Cited by 35
Comparison of novel delivery systems for antisense peptide nucleic acids.
Chiarantini, L., Cerasi, A., Fraternale, A., Millo, E., Benatti, U., Sparnacci, K., Laus, M., Ballestri, M., & Tondelli, L. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.09.013 · Cited by 33
Barrett, S. E., Burke, R. S., Abrams, M. T., Bason, C., Busuek, M., Carlini, E. J., Carr, B., Crocker, L. S., Fan, H., Garbaccio, R. M., et al. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.03.028 · Cited by 33
Efficient Intracellular Delivery of siRNA with A Safe Multitargeted Lipid-Based Nanoplatform
Gomes-da-Silva, L. C., Fernández, Y., Abasolo, I., Schwartz, S., Ramalho, J. S., de Lima, M. C. P., Simões, S., & Moreira, J. N. (2013) · Nanomedicine · doi:10.2217/nnm.12.174 · Cited by 26
Cell-Specific siRNA Delivery by Peptides and Antibodies
Lee, S., Siefert, A. L., Beloor, J., Fahmy, T. M., & Kumar, P. (2011) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-416039-2.00005-7 · Cited by 24
Kim, S. H., Hyeon, L. S., Tian, H., Chen, X., & Park, T. G. (2009) · Journal of drug targeting · doi:10.1080/10611860902767232 · Cited by 22
Lentiviral Vector-Mediated Gene Transfer and RNA Silencing Technology in Neuronal Dysfunctions
Dreyer, J. (2009) · Methods in molecular biology · doi:10.1007/978-1-60761-533-0_1 · Cited by 18
Novel Targeted Liposomes Deliver siRNA to Hepatocellular Carcinoma Cells in vitro
Dorasamy, S., Narainpersad, N., Singh, M., et al. (2012) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2012.01446.x · Cited by 14
Cited by
The Limitless Future of RNA Therapeutics
Damase, T. R., Sukhovershin, R., Boada, C., Taraballi, F., Pettigrew, R. I., & Cooke, J. P. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.628137 · Cited by 544
The growth of siRNA-based therapeutics: updated clinical studies
Zhang, M. M., Bahal, R., Rasmussen, T. P., Manautou, J. E., & Zhong, X.-B. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114432 · Cited by 497
Targeting non-coding RNAs to overcome cancer therapy resistance
Chen, B., Dragomir, M. P., Yang, C., Li, Q., Horst, D., & Calin, G. A. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00975-3 · Cited by 435
Hyaluronic acid and its biomedical applications: A review
Dovedytis, M., Liu, Z. J., & Bartlett, S. (2020) · Engineered Regeneration · doi:10.1016/j.engreg.2020.10.001 · Cited by 413
Triple-Negative Breast Cancer: A Review of Conventional and Advanced Therapeutic Strategies
Medina, M. A., Oza, G., Sharma, A., Arriaga, L. G., Hernández Hernández, J. M., Rotello, V. M., & Ramirez, J. T. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17062078 · Cited by 333
Metadata
- Authors
- Department of Biology, D. B., Dana, H., Chalbatani, G. M., Mahmoodzadeh, H., Gharagouzlo, E., Cancer Research Center, C. I. O. I., Karimloo, R., Department of Medicine, Z. M. S., Rezaiean, O., Moradzadeh, A., Mazraeh, A., Marmari, V., Rashno, M. M., Department of Biology, D. B., Mehmandoost, N., Department of chemistry, U. O. S. A. B., Moazzen, F., Department of Laboratory sciences, Z. B., Ebrahimi, M., Department of Biology, U. O. T., Abadi, S. J., & Department of Microbiology, S. M. S.
- Venue
- International Journal of Biomedical Science
- Published
- 2017-06-15
- Volume
- 13
- Issue
- 2
- Pages
- 48-57
- ISSN
- 1550-9702 (ISSN-L)
- 1555-2810
- OpenAlex
- W2968492662
- Cited by
- 505
- References
- 147
- FWCI
- 7.96
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.